These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 10576212

  • 1. Sequence-specific inhibition of gene expression in intact human skin by epicutaneous application of chimeric antisense oligodeoxynucleotides.
    Wingens M, Pfundt R, van Vlijmen-Willems IM, van Hooijdonk CA, van Erp PE, Schalkwijk J.
    Lab Invest; 1999 Nov; 79(11):1415-24. PubMed ID: 10576212
    [Abstract] [Full Text] [Related]

  • 2. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
    Alt M, Renz R, Hofschneider PH, Paumgartner G, Caselmann WH.
    Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
    [Abstract] [Full Text] [Related]

  • 3. Control of intracellular delivery of oligonucleotides by signal peptides and genetic expression in human cells.
    Kubo T, Kanno K, Ohba H, Rumiana B, Fujii M.
    Nucleic Acids Symp Ser (Oxf); 2004 Sep; (48):303-4. PubMed ID: 17150599
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNA chimeric oligonucleotides.
    Park WS, Miyano-Kurosaki N, Abe T, Takai K, Yamamoto N, Takaku H.
    Biochem Biophys Res Commun; 2000 Apr 21; 270(3):953-60. PubMed ID: 10772932
    [Abstract] [Full Text] [Related]

  • 5. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.
    Reed JC, Stein C, Subasinghe C, Haldar S, Croce CM, Yum S, Cohen J.
    Cancer Res; 1990 Oct 15; 50(20):6565-70. PubMed ID: 2208117
    [Abstract] [Full Text] [Related]

  • 6. Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia.
    Pfundt R, van Ruissen F, van Vlijmen-Willems IM, Alkemade HA, Zeeuwen PL, Jap PH, Dijkman H, Fransen J, Croes H, van Erp PE, Schalkwijk J.
    J Clin Invest; 1996 Sep 15; 98(6):1389-99. PubMed ID: 8823304
    [Abstract] [Full Text] [Related]

  • 7. An oligomer complementary to the 5' end region of MDR1 gene decreases resistance to doxorubicin of human adenocarcinoma-resistant cells.
    Corrias MV, Tonini GP.
    Anticancer Res; 1992 Sep 15; 12(5):1431-8. PubMed ID: 1444203
    [Abstract] [Full Text] [Related]

  • 8. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
    Normand N, Valamanesh F, Savoldelli M, Mascarelli F, BenEzra D, Courtois Y, Behar-Cohen F.
    Mol Vis; 2005 Mar 04; 11():184-91. PubMed ID: 15761390
    [Abstract] [Full Text] [Related]

  • 9. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C, Wellham LL.
    Anticancer Res; 2003 Mar 04; 23(3B):2681-90. PubMed ID: 12894558
    [Abstract] [Full Text] [Related]

  • 10. Demonstration of skin-derived antileukoproteinase (SKALP) and its target enzyme human leukocyte elastase in squamous cell carcinoma.
    Alkemade HA, van Vlijmen-Willems IM, van Haelst UJ, van de Kerkhof PC, Schalkwijk J.
    J Pathol; 1994 Oct 04; 174(2):121-9. PubMed ID: 7965407
    [Abstract] [Full Text] [Related]

  • 11. Identification of potentially effective antisense oligodeoxyribonucleotide (ODN) sequences for inhibiting plasminogen activator inhibitor-2 (PAI-2) production by monocytes.
    Humphries J, Burnand KG, Cunningham P, Brock A, Westwood N, Smith A.
    Thromb Haemost; 2002 Jul 04; 88(1):131-6. PubMed ID: 12152653
    [Abstract] [Full Text] [Related]

  • 12. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M, Shchepinov M, Sohail M, Benter IF, Hollins AJ, Southern EM, Akhtar S.
    J Control Release; 2004 Sep 14; 99(1):139-55. PubMed ID: 15342187
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liver.
    Robaczewska M, Guerret S, Remy JS, Chemin I, Offensperger WB, Chevallier M, Behr JP, Podhajska AJ, Blum HE, Trepo C, Cova L.
    Gene Ther; 2001 Jun 14; 8(11):874-81. PubMed ID: 11423935
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of interferon-gamma-induced intercellular adhesion molecule-1 expression on human keratinocytes by phosphorothioate antisense oligodeoxynucleotides is the consequence of antisense-specific and antisense-non-specific effects.
    Hertl M, Neckers LM, Katz SI.
    J Invest Dermatol; 1995 May 14; 104(5):813-8. PubMed ID: 7738361
    [Abstract] [Full Text] [Related]

  • 15. Relative levels of inhibition of p24 gene expression by different 20-mer antisense oligonucleotide sequences targeting nucleotides + 1129 to + 1268 of the HIV-1 gag genome: an analysis of mechanism.
    Anazodo MI, Duta E, Friesen AD, Wright JA.
    Biochem Biophys Res Commun; 1996 Dec 04; 229(1):305-9. PubMed ID: 8954123
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line.
    Gong ZB, Liu JM, Li YM.
    Hepatobiliary Pancreat Dis Int; 2005 Aug 04; 4(3):433-6. PubMed ID: 16109531
    [Abstract] [Full Text] [Related]

  • 17. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G, Scarsella M, Semple SC, Mottolese M, Natali PG, Leonetti C.
    Clin Cancer Res; 2005 Mar 01; 11(5):1990-8. PubMed ID: 15756025
    [Abstract] [Full Text] [Related]

  • 18. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides.
    Galderisi U, Di Bernardo G, Melone MA, Galano G, Cascino A, Giordano A, Cipollaro M.
    J Cell Biochem; 1999 Jul 01; 74(1):31-7. PubMed ID: 10381259
    [Abstract] [Full Text] [Related]

  • 19. Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids.
    Liu Y, Braasch DA, Nulf CJ, Corey DR.
    Biochemistry; 2004 Feb 24; 43(7):1921-7. PubMed ID: 14967032
    [Abstract] [Full Text] [Related]

  • 20. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS.
    Clin Cancer Res; 2002 Feb 24; 8(2):607-14. PubMed ID: 11839683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.